Pengaruh Insulin, Jahe dan Kombinasi Keduanya Terhadap Jumlah Sel Trofoblas Rattus Norvegicus Model Diabetes Pragestasional

Alif Zahrotin

Abstract

Diabetes mellitus (DM) is a metabolic disease with characteristics of hyperglycemia that has an effect on increasing morbidity and mortality in the mother. One of the complications of pregestational DM (pGDM) is preeclampsia (PE). The perinatal mortality rate increases 20x in pGDM women with PE complication. Exposure to hyperglycemia causes an increase in oxidative stress that increases apoptosis of trophoblast cells which in turn causes the decrease of proliferation and the number of trophoblastic cells and leads to endothelial dysfunction and hypoxia. The purpose of this study was to distinguish the effect of insulin administration and ginger extract on the number of trophoblast cells of R. norvegicus. This research was an experimental research using post-test only control group design. The population used were pregnant R. norvegicus. The sampling technique was simple random sampling with independent variables are insulin and Z. officinale extract and the dependent variable is the number of trophoblast cells. Data analysis of the number of trophoblast cells used wereKruskal-Wallis and Mann-Whitney test. The result showed that there was a significant difference in the trophoblast cell number with p-value <0,05 (p = 0,001) on positive control with insulin treatment group. The conclusion of this study was the presence of ginger extract can be used as a single therapy or combination with insulin for pregestational diabetes.

Keywords

penelitian

References

ADA (American Diabetes Association). 2010. ‘Diagnosis and classification of Diabetes mellitus’. Journal of diabetes, volume 33

Akash MSH, Rehman K, Tariq M, Chen S. 2015. ‘Zingiber officinale and type 2 diabetes mellitus:evidance from expperimental study’. Reasearch gate

https://www.researchgate.net/publication/273507313_Zingiber_officinale_and_Type_2_Diabetes_Mellitus_Evidence_from_Experimental_Studies (diakses:1 februari 2017)

Al-Amin ZM, Thomson M, Khaled, Shalaby RP, Ali M. 2006. ‘Antidiabetic and hypolipidemic properties of ginger (zingiber officinale) in streptozotocin-induced diabetic rats’. British journal of nutrition 96. 660-666

Bhatt N, Mostafa, Waly, Essa MM, Ali A. 2016. ‘Ginger:A functional herb’. Reasearg gate

CDC. 2012. ‘Diabetes cost-effectiveness group cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes’. JAMA. ;287(19):2542–51

Cerf, ME. 2013. ‘Beta cell dysfunction and insulin resistence’. Frontiers in endicronology

Cohen AL, Wenger JB, Todd TJ, Lamparello BM, Halprin E, Serdy S, Fan S, Horowitz GL, Lim KH, Rana S, Takoudes TC, Wyckoff JA, Thadhani R, Karumanchi SA and Brown FM. 2014. ‘The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with pre-existing diabetes’. Informa healthcare USA hypertensive pregnancy 2014;33(1):81-92

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Roase DJ and Spong CY. 2014. Williams obstetrics (24rd ed). New York,USA: McGraw-Hill

Larger O. 2015. The diabetes in pregnancy dilemma: leading change with proven solutions, 2e. USA: FMPH USA. Copyright

Li Y, Tran VH, Duke CC, Roufagalis BD. 2012. ‘Preventive and protective properties of zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorder: a brief review’. Hindawi publishing corporation evidance-based complementaryand alternative medicine volume 2012, article ID516870, 10 pages

Ojewole JAO. 2006. ‘Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of zingiber officinale (roscoe) rhizomes (zingiberacae) in mice and rats’. Phytotherapy research, vol. 20, no. 9, pp. 764-772

Palacios R, Alcaraz R, Campillo S, Larque E. 2017. ‘Role of Insulin in Placental Transport of Nutrients in Gestational Diabetes Mellitus’. Annals of Nutrition and metabolism

Sen P, Sahu K, Prasad P, Chandkrakar S, Sahu RK, Roy A. 2016. ‘Approach to phytochemistry and mechanism of action having antidiabetic activity’. UK Journal of pharmaceutical and bisciences vol. 4(1)82-120

Shibuya, M. 2012. ‘Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis. A Crucial Target for Anti- and Pro-Angiogenic Therapies’. Genes and Cancer 1097-1105

Uddin MN, Horvat D, Roth AI, Pringle KG, Allen SR, Jones RO, Zawieja, Kuehl TJ. 2013. ‘Hyperglycemia induces an antiangiogenic milieu in first trimester cytotrophoblast cell’. FASEB J. 27: 835.5

Weiss U, Cerver M, Peurstener P, Schmut O, Haas J, Mauschitz R, Arikan G, Desoye G. 2001. ‘Hyperglycemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast’. Diabetologia.44:2009-219

Zorn TMT, Zuniga M, Madrid E, Tostes R, Foertes Z, Giachini F and Martin S. 2011. ‘Maternal diabetes affects cell proliferation in developing rat placenta’. Histology and histopathology cellular and molecular biology, v.26, n.8, p.1049-1056


DOI: http://dx.doi.org/10.30651/qm.v2i01.641